These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7107408)

  • 1. Intracellular localization of radioactively labeled misonidazole in EMT-6-tumor cells in vitro.
    Miller GG; Ngan-Lee J; Chapman JD
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):741-4. PubMed ID: 7107408
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of binding of [3H]misonidazole and [14C]misonidazole in multicell spheroids.
    Rasey JS; Grunbaum Z; Krohn K; Nelson N; Chin L
    Radiat Res; 1985 Mar; 101(3):473-9. PubMed ID: 3983363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of 14C-misonidazole to hypoxic cells in V79 spheroids.
    Franko AJ; Chapman JD
    Br J Cancer; 1982 May; 45(5):694-9. PubMed ID: 7082555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.
    Raleigh JA; Franko AJ; Koch CJ; Born JL
    Br J Cancer; 1985 Feb; 51(2):229-35. PubMed ID: 3966980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The labelling of EMT-6 tumours in BALB/C mice with 14C-misonidazole.
    Garrecht BM; Chapman JD
    Br J Radiol; 1983 Oct; 56(670):745-53. PubMed ID: 6616139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro metabolism of misonidazole.
    Josephy PD; Palcic B; Skarsgard LD
    Br J Cancer; 1981 Apr; 43(4):443-50. PubMed ID: 7236487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A metabolite of the 2-nitroimidazole misonidazole with radiosensitizing properties.
    Flockhart IR; Sheldon PW; Stratford IJ; Watts ME
    Int J Radiat Biol Relat Stud Phys Chem Med; 1978 Jul; 34(1):91-4. PubMed ID: 309446
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of misonidazole and its derivatives by xanthine oxidase.
    Josephy PD; Palcic B; Skarsgard LD
    Biochem Pharmacol; 1981 Apr; 30(8):849-53. PubMed ID: 6894696
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative misonidazole metabolism in anaerobic bacteria and hypoxic Chinese hamster lung fibroblast (V-79-473) cells.
    Koch RL; Rose C; Rich TA; Goldman P
    Biochem Pharmacol; 1982 Feb; 31(3):411-4. PubMed ID: 7073768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of misonidazole to EMt6 and V79 spheroids.
    Franko AJ; Chapman JD; Koch CJ
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):737-9. PubMed ID: 7107407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. An overview.
    Adams GE; Stratford IJ
    Biochem Pharmacol; 1986 Jan; 35(1):71-6. PubMed ID: 2934067
    [No Abstract]   [Full Text] [Related]  

  • 12. Polarographic measurement of misonidazole in mouse mammary tumors.
    Ohizumi Y; Maezawa H; Murayama C; Mori T
    Tokai J Exp Clin Med; 1984 Aug; 9(3):199-206. PubMed ID: 6537667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxic fraction and binding of misonidazole in EMT6/Ed multicellular tumor spheroids.
    Franko AJ
    Radiat Res; 1985 Jul; 103(1):89-97. PubMed ID: 4070561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ drug delivery.
    Levin VA; Wright DC; Landahl HD; Patlak CS; Csejtey J
    Br J Cancer Suppl; 1980 Apr; 4():74-8. PubMed ID: 6932949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further characterization of 4-bromomisonidazole as a potential detector of hypoxic cells.
    Rasey JS; Krohn KA; Grunbaum Z; Conroy PJ; Bauer K; Sutherland RM
    Radiat Res; 1985 Apr; 102(1):76-85. PubMed ID: 3983371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in misonidazole binding with hypoxic fraction in mouse tumors.
    Hirst DG; Hazlehurst JL; Brown JM
    Int J Radiat Oncol Biol Phys; 1985 Jul; 11(7):1349-55. PubMed ID: 4008291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
    Varghese AJ; Whitmore GF
    Cancer Res; 1980 Jul; 40(7):2165-9. PubMed ID: 6155991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional measurements of [14C]misonidazole distribution and blood flow in subcutaneous RT-9 experimental tumors.
    Blasberg R; Horowitz M; Strong J; Molnar P; Patlak C; Owens E; Fenstermacher J
    Cancer Res; 1985 Apr; 45(4):1692-701. PubMed ID: 3978636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-enhanced reduction and covalent binding of [2-3H]misonidazole in the perfused rat liver.
    Smith BR
    Biochem Pharmacol; 1984 Apr; 33(8):1379-81. PubMed ID: 6201179
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of hypoxia on the metabolism and excretion of misonidazole by the isolated perfused rat liver--a model system.
    Smith BR; Born JL; Garcia DJ
    Biochem Pharmacol; 1983 May; 32(10):1609-12. PubMed ID: 6860347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.